Kraig Biocraft Laboratories, Inc.
KBLB
$0.085
-$0.004-4.49%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -15.07% | 64.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.91% | 68.92% | |||
| Operating Income | 18.91% | -68.92% | |||
| Income Before Tax | 29.55% | -96.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 29.55% | -96.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 29.55% | -96.61% | |||
| EBIT | 18.91% | -68.92% | |||
| EBITDA | 19.03% | -70.20% | |||
| EPS Basic | 25.00% | -100.00% | |||
| Normalized Basic EPS | 20.00% | -66.67% | |||
| EPS Diluted | 25.00% | -100.00% | |||
| Normalized Diluted EPS | 20.00% | -66.67% | |||
| Average Basic Shares Outstanding | 0.30% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||